FRA:FRE - Fresenius SE & Co KGaA Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
€68.30 -0.30 (-0.44 %)
(As of 06/19/2018 07:10 AM ET)
Previous Close€68.60
Today's Range€66.96 - €68.44
52-Week Range€60.16 - €80.00
Volume487,512 shs
Average VolumeN/A
Market Capitalization$35.76 billion
P/E RatioN/A
Dividend Yield1.16%
Fresenius SE & Co KGaA logoFresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure. This segment offers dialyzers, dialysis machines, and renal pharmaceuticals, as well as dialysis- related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs comprising intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products used in the collection and processing whole blood and blood components, as well as in transfusion medicine. The Fresenius Helios segment operates approximately 112 hospitals, including 88 acute care hospitals and 24 post-acute care clinics; 78 outpatient clinics; 4 out-patient post-acute care centers; 18 prevention centers; and 13 nursing homes. This segment has approximately 35,000 beds. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as provides maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg, Germany.

Receive FRE News and Ratings via Email

Sign-up to receive the latest news and ratings for FRE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding Shares554,300,000

Fresenius SE & Co KGaA (FRA:FRE) Frequently Asked Questions

What is Fresenius SE & Co KGaA's stock symbol?

Fresenius SE & Co KGaA trades on the FRA under the ticker symbol "FRE."

What price target have analysts set for FRE?

21 equities research analysts have issued 12-month price targets for Fresenius SE & Co KGaA's shares. Their predictions range from €59.00 to €85.00. On average, they anticipate Fresenius SE & Co KGaA's stock price to reach €78.52 in the next twelve months. View Analyst Ratings for Fresenius SE & Co KGaA.

Who are Fresenius SE & Co KGaA's key executives?

Fresenius SE & Co KGaA's management team includes the folowing people:
  • Gerd Krick, Chairman of the Supervisory Board
  • Stephan Sturm, Chief Executive Officer (Age 52)
  • Niko Stumpfoegger, Deputy Chairman of the Supervisory Board, Employee Representative
  • Juergen Goetz, Chief Legal and Compliance Officer, Labor Relations Director, Member of the Management Board
  • Francesco De Meo, Member of the Management Board, Chief Executive Officer of Fresenius Helios
  • Mats Christer Henriksson, Member of the Management Board, Chief Executive Officer Fresenius Kabi
  • Rice Powell, Member of the Management Board, Chief Executive Officer of Fresenius Medical Care (Age 61)
  • Ernst Wastler, Member of the Management Board, Chief Executive Officer Fresenius Vamed
  • D. Michael Albrecht, Member of the Supervisory Board
  • Michael Diekmann, Member of the Supervisory Board (Age 63)

Has Fresenius SE & Co KGaA been receiving favorable news coverage?

Media coverage about FRE stock has trended somewhat positive recently, according to Accern Sentiment. Accern rates the sentiment of news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Fresenius SE & Co KGaA earned a coverage optimism score of 0.10 on Accern's scale. They also assigned headlines about the company an impact score of 44.98 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

What is Fresenius SE & Co KGaA's stock price today?

One share of FRE stock can currently be purchased for approximately €67.86.

How big of a company is Fresenius SE & Co KGaA?

Fresenius SE & Co KGaA has a market capitalization of $35.76 billion.

How can I contact Fresenius SE & Co KGaA?

Fresenius SE & Co KGaA's mailing address is Else-Kroener-Str. 1, BAD HOMBURG VOR DER HOEHE, 61352, Germany. The company can be reached via phone at +49-6172-6080.

MarketBeat Community Rating for Fresenius SE & Co KGaA (FRE)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  163 (Vote Outperform)
Underperform Votes:  104 (Vote Underperform)
Total Votes:  267
MarketBeat's community ratings are surveys of what our community members think about Fresenius SE & Co KGaA and other stocks. Vote "Outperform" if you believe FRE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FRE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/19/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.